Clinical value of drugs of abuse point of care testing in an emergency department setting
Objective: Toxicology screening tests for drugs-of-abuse and therapeutic drugs in urine (TST-U) are often used to assess whether a patient’s clinical condition can be explained by the use of drugs-of-abuse (DOA) and/or therapeutic drugs. TST-U have clinical value when they support clinical decision...
Main Authors: | P.S. Lager, M.E. Attema-de Jonge, M.P. Gorzeman, L.E. Kerkvliet, E.J.F. Franssen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | Toxicology Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221475001730104X |
Similar Items
-
Toxicological screening in the Amsterdam acute setting becomes more relevant if the standard panel of the drugs-of-abuse point-of-care test is expanded with GHB and ketamine
by: J.A.J. van der Schaar, et al.
Published: (2020-01-01) -
Emergency Department Visits Involving Misuse and Abuse of the Antipsychotic Quetiapine: Results from the Drug Abuse Warning Network (DAWN)
by: Margaret E. Mattson, et al.
Published: (2015-01-01) -
Emergency Department Visits Involving Misuse and Abuse of the Antipsychotic Quetiapine: Results from the Drug Abuse Warning Network (DAWN)
by: Margaret E. Mattson, et al.
Published: (2015-05-01) -
Facilitators and barriers to screening for child abuse in the emergency department
by: Louwers Eveline CFM, et al.
Published: (2012-10-01) -
Screening for abuse in emergency departments: A pending issue
by: Ana I. Curcoy, et al.
Published: (2020-11-01)